Iceland· IS-930291
Pulmozyme
A dornase alfa (desoxyribonuclease) product containing dornase alfa inn, registered in Iceland by Roche Pharmaceuticals A/S. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Dornase alfa (desoxyribonuclease) is registered in 11 of 19 countries.
Countries holding a registration under ATC R05CB13 (dornase alfa (desoxyribonuclease)), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Dornase alfa (desoxyribonuclease) · ATC R05CB13
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Dornase alfa INN
- Manufacturer
- Roche Pharmaceuticals A/S
- Country
- Iceland (IS)
- ATC code
- R05CB13
- ATC class
- Dornase alfa (desoxyribonuclease)
- Defined daily dose
- 2.5 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean1482132,5 ml x30 lykjurISK 115806
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for dornase alfa (desoxyribonuclease).
Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dornase alfa (desoxyribonuclease) · interactions on record
5 records
- 5 moderate
Most severe, free to view
- Insulin (human)A10AB01moderate
- Insulin (human)A10AC01moderate
- Insulin (human)A10AD01moderate
- Insulin (human)A10AE01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dornase alfa (desoxyribonuclease) in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenPulmozyme 1 mg/ml Lösning för nebulisatorOrifarm AB
- FinlandPulmozymeRoche Oy
- NetherlandsPulmozyme, inhalatievloeistof 1 mg/ml, 2,5 mlEU-Pharma B.V.
- NorwayPulmozymeRoche Norge AS
- PolandPulmozymeRoche Polska Sp. z o.o.
- United StatesPulmozymeGenentech, Inc.
- United KingdomPulmozyme 2.5mg nebuliser liquid 2.5ml ampoulesRoche Products Ltd
- IrelandPulmozyme 2500 U/ 2.5ml, nebuliser solutionRoche Products (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Pulmozyme
- Belgium · Pulmozyme
- Bulgaria · Пулмозим
- Cyprus · Pulmozyme
- Czechia · Pulmozyme
- Germany · Pulmozyme
- Denmark · Pulmozyme
- Estonia · Pulmozyme
- Spain · Pulmozyme
- Finland · Pulmozyme
- France · Pulmozyme
- United Kingdom (Northern Ireland) · Pulmozyme
- Greece · Pulmozyme
- Croatia · Pulmozyme Otopina Za Atomizator
- Hungary · Pulmozyme
- Ireland · Pulmozyme
- Italy · Pulmozyme
- Lithuania · Pulmozyme
- Luxembourg · Pulmozyme
- Latvia · Pulmozyme
- Netherlands · Pulmozyme Verneveloplossing
- Norway · Pulmozyme
- Poland · Pulmozyme
- Portugal · Pulmozyme
- Romania · Pulmozyme
- Sweden · Pulmozyme
- Slovenia · Pulmozyme
- Slovakia · Pulmozyme
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6f90e4a5-94a2-4334-924a-2eb43725bee5 GET /v1/drugs/6f90e4a5-94a2-4334-924a-2eb43725bee5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Lausn í eimgjafa",
"source": "lyfjastofnun",
"atc_raw": "R05CB13",
"marketed": true,
"strength": "1 mg/ml",
"ma_number": "930291",
"substance": "Dornase alfa INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í barnalækningum með sérþekkingu á slímseigjusjúkdómi (cystic fibrosa) sérfræðinga í lungnasjúkdómum og tannlækna með sérfræðimenntun.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "35065"
}See everything about dornase alfa (desoxyribonuclease).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.